DES MOINES, Iowa, Jan. 7, 2026 /PRNewswire/ — BioSpace, the leading life sciences news and careers site, has announced its 2026 selections for the industry’s mostDES MOINES, Iowa, Jan. 7, 2026 /PRNewswire/ — BioSpace, the leading life sciences news and careers site, has announced its 2026 selections for the industry’s most

BioSpace Names 15 Top Startups to Watch in 2026

DES MOINES, Iowa, Jan. 7, 2026 /PRNewswire/ — BioSpace, the leading life sciences news and careers site, has announced its 2026 selections for the industry’s most promising up-and-coming companies.

The NextGen Class of 2026 list showcases 15 innovative organizations demonstrating exciting potential. This is the 12th year BioSpace has highlighted the most anticipated new biopharma companies from across the U.S.

BioSpace‘s editorial team considered multiple factors: financing, collaborations, pipeline, growth potential and innovation. This year’s list includes companies that announced initial, seed or series A rounds between October 1, 2024, and September 30, 2025.

“Startups faced a challenging funding and regulatory environment in 2025,” said BioSpace CEO Josh Goodwin. “The successful raises of these companies shows how well they have been able to adapt and navigate this dynamic landscape.”

BioSpace considers organizations across all therapeutic areas. RNA therapies, antisense oligonucleotides and CAR Ts are among the products being developed. Winners include Kardigan, Light Horse, Haya and City Therapeutics.

“It was a smaller NextGen class this year, given the tight funding environment,” said BioSpace Managing Editor Jef Akst. “The companies highlighted standout not only for their raises but their innovative science, a lot of which has already attracted Big Pharma partners.”

“Picking the annual NextGen list is a highlight of the year for BioSpace‘s editorial team. It gives us a window into the biotechs that will be driving the industry’s innovations and headlines in the years to come,” said BioSpace Senior Editor Annalee Armstrong.

Last year’s NextGen list included obesity startup Metsera, which made headlines with a dramatic bidding war that eventually ended with a $10 billion Pfizer buy. Other 2025 NextGen members continue to be closely watched by the industry, such as Seaport Therapeutics, which accrued multiple best-in-biotech accolades.

The NextGen: Class of 2026 List

Arnatar Therapeutics, Axonis Therapeutics, Bambusa Therapeutics, City Therapeutics, Corsera Health, Dispatch Bio, Haya Therapeutics, Helicore, Kardigan Therapeutics, Kivu Bioscience, Light Horse Therapeutics, Newleos Therapeutics, Renasant Bio, Stylus Medicine, Trace Neuroscience

View complete NextGen lists from previous years: Class of 2025, Class of 2024, Class of 2023, Class of 2022, Class of 2021, Class of 2020, Class of 2019, Class of 2018, Class of 2017, Class of 2016, Class of 2015.

About BioSpace

BioSpace provides essential insights, opportunities and tools to connect innovative life sciences organizations and talented professionals who advance health and quality of life across the globe. BioSpace is the leading source for careers and news for life sciences professionals in the United States. 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/biospace-names-15-top-startups-to-watch-in-2026-302654099.html

SOURCE BioSpace

Market Opportunity
TOP Network Logo
TOP Network Price(TOP)
$0.000096
$0.000096$0.000096
0.00%
USD
TOP Network (TOP) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Indonesia approves $70 million-backed ICEx as the country's second official cryptocurrency exchange.

Indonesia approves $70 million-backed ICEx as the country's second official cryptocurrency exchange.

PANews reported on January 12th, citing Techinasia, that Indonesia's financial regulator, the Financial Services Authority (OJK), has granted International Crypto
Share
PANews2026/01/12 09:36
Homeland Security to send hundreds more officers to Minnesota, Noem says

Homeland Security to send hundreds more officers to Minnesota, Noem says

Some 2,000 federal officers have already been dispatched to the Minneapolis-St. Paul area in what DHS has called its largest operation ever
Share
Rappler2026/01/12 09:30
Top Solana Treasury Firm Forward Industries Unveils $4 Billion Capital Raise To Buy More SOL ⋆ ZyCrypto

Top Solana Treasury Firm Forward Industries Unveils $4 Billion Capital Raise To Buy More SOL ⋆ ZyCrypto

The post Top Solana Treasury Firm Forward Industries Unveils $4 Billion Capital Raise To Buy More SOL ⋆ ZyCrypto appeared on BitcoinEthereumNews.com. Advertisement &nbsp &nbsp Forward Industries, the largest publicly traded Solana treasury company, has filed a $4 billion at-the-market (ATM) equity offering program with the U.S. SEC  to raise more capital for additional SOL accumulation. Forward Strategies Doubles Down On Solana Strategy In a Wednesday press release, Forward Industries revealed that the 4 billion ATM equity offering program will allow the company to issue and sell common stock via Cantor Fitzgerald under a sales agreement dated Sept. 16, 2025. Forward said proceeds will go toward “general corporate purposes,” including the pursuit of its Solana balance sheet and purchases of income-generating assets. The sales of the shares are covered by an automatic shelf registration statement filed with the US Securities and Exchange Commission that is already effective – meaning the shares will be tradable once they’re sold. An automatic shelf registration allows certain publicly listed companies to raise capital with flexibility swiftly.  Kyle Samani, Forward’s chairman, astutely described the ATM offering as “a flexible and efficient mechanism” to raise and deploy capital for the company’s Solana strategy and bolster its balance sheet.  Advertisement &nbsp Though the maximum amount is listed as $4 billion, the firm indicated that sales may or may not occur depending on existing market conditions. “The ATM Program enhances our ability to continue scaling that position, strengthen our balance sheet, and pursue growth initiatives in alignment with our long-term vision,” Samani said. Forward Industries kicked off its Solana treasury strategy on Sept. 8. The Wednesday S-3 form follows Forward’s $1.65 billion private investment in public equity that closed last week, led by crypto heavyweights like Galaxy Digital, Jump Crypto, and Multicoin Capital. The company started deploying that capital this week, announcing it snatched up 6.8 million SOL for approximately $1.58 billion at an average price of $232…
Share
BitcoinEthereumNews2025/09/18 03:42